What must a med spa in New Jersey report to the board?

Facility · part of The Practice Perimeter

Short answer
The licensee must notify the Board when terminating an affiliation with a general business corporation — and must sever that affiliation where the entity repeatedly fails to keep the required quality-control mechanisms and refuses to add them on request.

A licensee must sever an employment or affiliation where the entity regularly fails to maintain the required quality-control mechanisms and refuses to put them in place on request, and must notify the Board when terminating an affiliation with a general business corporation.

N.J.A.C. 13:35-6.16(g) · verified Aug 17, 2026 · regulatory monitoring, not legal advice

Related New Jersey rules

  • ⚠️ New Jersey bars compounded sterile stock for human practice, and permits it for animals. “in the absence of a valid patient-specific prescription or medication order, pharmacists, pharmacy technicians, pharmacy interns, and pharmacy externs shall not prepare compounded sterile preparations for human use for a licensed prescriber to use in his or her practice, except to the extent permitted by federal law.” The very next sentence lets a pharmacy prepare them for a prescriber “for non-human use … without a prescription”. The federal exception is the 503B door.

    N.J.A.C. 13:39-11.18 · verified Sep 2, 2026 · read at Internet Archive snapshot — evidence of a page, not the current rule

  • ⚠️ and compounding a drug you could buy needs one of two justifications. “a pharmacist shall not compound any commercially available drug products unless: 1) The commercially available product is modified to produce a significant difference, in the professional judgment of the prescriber, between the compounded product for the patient and the comparable commercially available product; OR 2) The commercially available product is not available from normal distribution channels in a timely manner to meet the patient’s needs, AND the dispensing of the compounded product has been approved by the prescriber and the patient.” Note route 2 needs the PATIENT’s approval as well as the prescriber’s.

    N.J.A.C. 13:39-11.25(b) · verified Sep 2, 2026 · read at Internet Archive snapshot — evidence of a page, not the current rule

All 8 cited New Jersey rules on med-spa registration & licensing →

How other states answer this

All 23 states side by side →

Related New Jersey questions

Every New Jersey question we can answer →

Get New Jersey changes as they publish

We scan the New Jersey legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.

Free · unsubscribe in one click · we never sell your address

← All New Jersey rules and changes · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director. Legislative data via LegiScan (CC BY 4.0).